The anti-CD20 antibody rituximab reduces the Th17 cell response
Year: 2011
Type: article
Study design: Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.30314
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2046188285
